Analyst price target for SOLV is US$87.18 which is 35% below our fair value estimate Does the January share price for ...
Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback